Daiichi Sankyo Launches Amgen's Bevacizumab In Japan

Comes Shortly After Pfizer Debuted First Japanese Avastin Rival

 
• By David Wallace
  
Daiichi Sankyo
Daiichi Sankyo has launched Amgen’s bevacizumab biosimilar in Japan • Source: Shutterstock

More from Products

More from Generics Bulletin